Ads
related to: latest news on heartburn medicine
Search results
Results from the WOW.Com Content Network
The drug, approved over four decades ago, had became the world's best selling medicine in 1988 and one of the first-ever drugs to top $1 billion in annual sales.
NEW YORK (Reuters) -Sanofi has reached an agreement in principle to settle 4,000 U.S. lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday. Sanofi did ...
(Reuters) -Pfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people ...
Ranitidine, a heartburn medicine sold under the brand name Zantac among others, was pulled from shelves in 2019, [1] following disclosure [2] of potential carcinogenic effects, [3] [4] which its manufacturers were accused of "engaging in a decades-long scheme to conceal." [5]
(Reuters) -Britain's AstraZeneca said it will pay $425 million to settle lawsuits in the United States that claimed its heartburn drugs Nexium and Prilosec caused chronic kidney disease.
Tums (stylized as TUMS) is an antacid made of sucrose (table sugar) and calcium carbonate (CaCO 3) manufactured by Haleon in St. Louis, Missouri, US.They are also available in a sugar-free version.
It is the second British drugmaker to reach a settlement in the United States for its heartburn drug after GSK in June agreed to settle a U.S. lawsuit alleging its discontinued treatment Zantac ...
First approved in 1983, Zantac, sold at different times by GSK, Pfizer, Sanofi and Boehringer Ingelheim, became the world's best-selling medicine in 1988 and one of the first to top $1 billion in ...
Ads
related to: latest news on heartburn medicine